Antiemetics And Antinauseants Market Grows At Rate Of Over 30% Through 2021, With Cancer Rates As A Key Driver

Antiemetics And Antinauseants Market Report 2021: COVID 19 Impact And Recovery To 2030

Antiemetics And Antinauseants Global Market Report 2021: COVID 19 Impact And Recovery To 2030

The Business Research Company’s Antiemetics And Antinauseants Global Market Report 2021: COVID-19 Impact and Recovery to 2030

LONDON, GREATER LONDON, UK, May 3, 2021 /EINPresswire.com/ — Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

The global antiemetics and antinauseants market is expected to grow from $2.29 billion in 2020 to $2.99 billion in 2021 at a compound annual growth rate (CAGR) of 30.6%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $3.98 billion in 2025 at a CAGR of 7.4%.

Antiemetics drugs market analysis shows that it is driven by the increase in the prevalence rate of cancer. Chemotherapy is one of the most recommended treatment to cure cancer, and chemotherapy-induced nausea and vomiting (CINV) are some of the side effects of the treatment. Antiemetics can help prevent CINV in about 60%-70% of patients. According to the WHO reports, the incidence of cancer globally has risen to 18.1 million new cases and 9.6 million deaths. According to another report by Centers for Disease Control and Prevention, about 650,000 cancer patients in the USA receive chemotherapy in an outpatient oncology clinic each year. The CINV caused by chemotherapy treatments is cured by using antiemetic and antinauseant drugs like Dolasetron (Anzemet®), Ranitidine (Zantac®) and other serotonin 5-HT3 receptor types of antagonists. Increase in the incidence of cancer will increase demand for antiemetics and antinauseants, thereby driving revenue for market.

Read More On The Global Antiemetics And Antinauseants Market Report:
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Major players in the antiemetics and antinauseants industry are Johnson & Johnson, Sanofi-Aventis, Pfizer, GlaxoSmithKline and Abbott Laboratories. The regions with antiemetics market shares covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global antiemetics and antinauseants market is segmented by drug into dopamine antagonists, NK1 receptor antagonist, antihistamines (H1 histamine receptor antagonists), cannabinoids, benzodiazepines, anticholinergics, steroids, 5-HT3 receptor antagonists, others, by application into chemotherapy, motion sickness, gastroenteritis, general anesthetics, opioid analgesics, dizziness, pregnancy, food poisoning, emotional stress, others, and by end users into hospital, medical center, clinic, research institutes.

Antiemetics And Antinauseants Global Market Report 2021: COVID 19 Impact and Recovery to 2030 is one of a series of new reports from The Business Research Company that provides antiemetics and antinauseants market overview, forecast antiemetics and antinauseants market size and growth for the whole market, antiemetics and antinauseants market segments, and geographies, antiemetics and antinauseants market trends, antiemetics and antinauseants market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Antiemetics And Antinauseants Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Oncology Drugs Market – By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Pharmaceutical Drugs Market – By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-market

Gastrointestinal Drugs Global Market Report 2021: COVID-19 Implications And Growth to 2030
https://www.thebusinessresearchcompany.com/report/gastrointestinal-drugs-global-market-report-2020-30-covid-19-implications-and-growth

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire